Your session is about to expire
← Back to Search
Neurostimulation Device
NEUROMARK™ System for Chronic Rhinitis (MERIDIEN Trial)
N/A
Waitlist Available
Research Sponsored by Neurent Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
MERIDIEN Trial Summary
This trial found that the NEUROMARKTM system was an effective treatment for chronic rhinitis.
Eligible Conditions
- Chronic Rhinitis
MERIDIEN Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Frequency of Serious Adverse Events (SAEs) directly attributable to the device
MERIDIEN Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: TreatmentExperimental Treatment1 Intervention
Subject in this arm will undergo treatment with the NEUROMARK device.
Group II: ShamPlacebo Group1 Intervention
Subjects in this arm will undergo the procedure with a Sham device. At 3 months post treatment these subjects will cross over to Arm 1.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NEUROMARK™ System
2021
N/A
~150
Find a Location
Who is running the clinical trial?
Neurent MedicalLead Sponsor
4 Previous Clinical Trials
398 Total Patients Enrolled
4 Trials studying Chronic Rhinitis
398 Patients Enrolled for Chronic Rhinitis
Annalise SorensenStudy DirectorNeurent Medical
3 Previous Clinical Trials
266 Total Patients Enrolled
3 Trials studying Chronic Rhinitis
266 Patients Enrolled for Chronic Rhinitis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this study currently looking for participants?
"The clinical trial in question is not recruiting patients at the moment, however this could change in the future. According to the information found on clinicaltrials.gov, the last update for this study was on April 4th, 2022. There are other 67 trials that are actively looking for participants right now."
Answered by AI
Share this study with friends
Copy Link
Messenger